Why Doesn’t the Gold Standard Treatment for Bipolar Disorder Work for the Majority of Patients? 💊🧠🔬
Lithium is considered to be the gold standard treatment for bipolar disorder (BD), but nearly 70% of people with BD do not respond to the treatment, leaving them at risk for debilitating, potentially life-threatening mood swings. Researchers at the Salk Institute have found that the culprit may lie in gene activity—or the lack of it. The study could result in a new drug for bipolar disorder as well as a biomarker for lithium non-responsiveness.